ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
GraniteShares YieldBOOST Biotech ETF
21.16
-0.0088
-0.04%
成交量:
1,455
成交额:
3.08万
市值:
84.64万
市盈率:
- -
高:
21.19
开:
21.15
低:
21.15
收:
21.17
52周最高:
25.28
52周最低:
20.66
股本:
4.00万
流通股本:
4.00万
量比:
1.59
换手率:
3.64%
股息:
4.18
股息率:
19.76%
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
港股早评:三大指数高开逾1.1%,生物科技股、黄金股大涨
中金财经
·
08/20
AI生物科技股Twist Bioscience涨超22%
格隆汇
·
08/20
受利好消息提振,美股生物科技股普涨
智通财经
·
08/19
深圳易慕峰生物科技股份有限公司向港交所提交IPO申请,华泰金融控股(香港)为保荐人兼整体协调人。
格隆汇
·
08/18
中国银河证券:实验动物为创新药研发刚需 小鼠+猴双主线高景气
智通财经
·
08/14
百花医药股价严重异常波动:主营小分子化学仿制药CRO业务 不涉及创新药研发
央广财经
·
08/12
百花医药(600721.SH):不涉及创新药研发
智通财经
·
08/11
百花医药(600721.SH):不涉及创新药研发
智通财经
·
08/11
东方证券:AI重构创新药研发底座 国内相关产业链公司亦有望受益
智通财经
·
08/11
创新药研发加速遇“猴荒”
三里河
·
07/22
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/BIOY/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIOY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOY\",,,,,undefined,":{"symbol":"BIOY","market":"US","secType":"STK","nameCN":"GraniteShares YieldBOOST Biotech ETF","latestPrice":21.1612,"timestamp":1787601600000,"preClose":21.17,"halted":0,"volume":1455,"delay":0,"changeRate":-0.00041568256967410515,"floatShares":40000,"shares":40000,"eps":0,"marketStatus":"盘前交易","change":-0.0088,"latestTime":"08-25 06:27:47 EDT","open":21.15,"high":21.1899,"low":21.15,"amount":30810,"amplitude":0.001885,"askPrice":33.64,"askSize":100,"bidPrice":21.19,"bidSize":81,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":21.1612,"nav":21.153005,"aum":846141.349805,"dividendRate":0.197583,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":21.1899,"preClose":21.1612,"latestTime":"16:04 EDT","volume":4,"amount":84.6448,"timestamp":1787601846988,"change":0.0287,"changeRate":0.001356,"amplitude":0},"volumeRatio":1.5901638301531915},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOY\",,,,,undefined,":{"symbol":"BIOY","floatShares":40000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.5901638301531915,"shares":40000,"dividePrice":4.1811,"high":21.1899,"amplitude":0.001885,"preClose":21.17,"low":21.15,"week52Low":20.655,"pbRate":"--","week52High":25.28,"institutionHeld":0,"latestPrice":21.1612,"committee":-0.104972,"eps":0,"divideRate":0.197583,"volume":1455,"delay":0,"ttmEps":0,"open":21.15,"prevYearClose":25.12,"prevWeekClose":21.17,"prevMonthClose":20.955,"prevQuarterClose":23.15,"fiveDayClose":21.205,"twentyDayClose":21.475,"sixtyDayClose":24.235},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIOY\",params:#limit:5,,,undefined,":[{"date":"2026-08-21","symbol":"BIOY","amount":0.24904,"announcedDate":"2026-08-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-21","defaultRemindTime":1787319000000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-25","payableDate":"2026-08-21","currency":"USD","dateTimestamp":1787284800000,"payDate":"2026-08-25"},{"date":"2026-08-14","symbol":"BIOY","amount":0.24507,"announcedDate":"2026-08-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-14","defaultRemindTime":1786714200000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-18","payableDate":"2026-08-14","currency":"USD","dateTimestamp":1786680000000,"payDate":"2026-08-18"},{"date":"2026-08-07","symbol":"BIOY","amount":0.23731,"announcedDate":"2026-08-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-07","defaultRemindTime":1786109400000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-11","payableDate":"2026-08-07","currency":"USD","dateTimestamp":1786075200000,"payDate":"2026-08-11"},{"date":"2026-07-31","symbol":"BIOY","amount":0.23954,"announcedDate":"2026-07-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-31","defaultRemindTime":1785504600000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-04","payableDate":"2026-07-31","currency":"USD","dateTimestamp":1785470400000,"payDate":"2026-08-04"},{"date":"2026-07-24","symbol":"BIOY","amount":0.25161,"announcedDate":"2026-07-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-24","defaultRemindTime":1784899800000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-28","payableDate":"2026-07-24","currency":"USD","dateTimestamp":1784865600000,"payDate":"2026-07-28"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIOY\",market:\"US\",,,undefined,":[{"executeDate":"2026-05-08","recordDate":"2026-05-08","paymentDate":"2026-05-12","value":0.28187,"currency":"USD"},{"executeDate":"2026-05-15","recordDate":"2026-05-15","paymentDate":"2026-05-19","value":0.29042,"currency":"USD"},{"executeDate":"2026-05-22","recordDate":"2026-05-22","paymentDate":"2026-05-27","value":0.2758,"currency":"USD"},{"executeDate":"2026-05-29","recordDate":"2026-05-29","paymentDate":"2026-06-02","value":0.27453,"currency":"USD"},{"executeDate":"2026-06-05","recordDate":"2026-06-05","paymentDate":"2026-06-09","value":0.2676,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIOY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIOY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660472972","title":"港股早评:三大指数高开逾1.1%,生物科技股、黄金股大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2660472972","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660472972?lang=zh_cn&edition=fundamental","pubTime":"2026-08-20 09:37","pubTimestamp":1787189821,"startTime":"0","endTime":"0","summary":"美股止住三连跌,日韩股市大幅反弹。港股三大指数集体高开,恒指涨1.11%,国指涨1.27%,恒生科技指数涨1.69%。大型科网股全线上涨,京东涨近3%,美团、阿里巴巴涨2%,腾讯、小米、百度皆上涨;mRNA肿瘤疫苗三期大获成功,全产业链迎来价值重估,生物医药股大涨,康希诺生物、云顶新耀大涨15%,金斯瑞生物科技大涨13%,金价大涨,黄金股领衔有色金属股上涨,另外,消费电子股、海运股、煤炭股部分走低。(格隆汇)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260820/32340660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BIOY","159562","KCAI","VXUS","BK4588","TBXU","BK4585","GLDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660476170","title":"AI生物科技股Twist Bioscience涨超22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660476170","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660476170?lang=zh_cn&edition=fundamental","pubTime":"2026-08-20 06:26","pubTimestamp":1787178401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BIOY","ARTY","QTOC","AGIX","AIPO","TBXU","VTHR","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660447273","title":"受利好消息提振,美股生物科技股普涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2660447273","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660447273?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 19:21","pubTimestamp":1787138473,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BIOY","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660304824","title":"深圳易慕峰生物科技股份有限公司向港交所提交IPO申请,华泰金融控股(香港)为保荐人兼整体协调人。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660304824","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660304824?lang=zh_cn&edition=fundamental","pubTime":"2026-08-18 07:26","pubTimestamp":1787009193,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["FRHC","REDS","TBXU","BK4127","IPOS","159940","BIOY","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659504119","title":"中国银河证券:实验动物为创新药研发刚需 小鼠+猴双主线高景气","url":"https://stock-news.laohu8.com/highlight/detail?id=2659504119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659504119?lang=zh_cn&edition=fundamental","pubTime":"2026-08-14 15:07","pubTimestamp":1786691225,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中国银河证券发布研报称,实验动物为创新药研发刚需,行业壁垒深厚,两大细分赛道具备中长期成长逻辑:人源化小鼠赛道成长确定性更强、周期波动平缓;实验猴赛道供给约束强,短期价格上行带来显著业绩弹性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","LFSC","601881","APXH","SBIO","XLVI","BBP","BIOY","BK0276","BK1147","BK1564","GSKH","BK0188","IBB","06881","BK4585","PBE","BK4588","GDOC","WRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903675","title":"百花医药股价严重异常波动:主营小分子化学仿制药CRO业务 不涉及创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903675","media":"央广财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658903675?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 21:27","pubTimestamp":1786541220,"startTime":"0","endTime":"0","summary":"8月12日,百花医药(维权)(600721.SH)发布公告称,公司股票连续10个交易日内日收盘价格涨幅偏离值累计超过100%,根据上交所的有关规定,属于股票交易严重异常波动情形。公司是以小分子化学仿制药研发为主的CRO企业,不涉及创新药研发。公司2026年第一季度实现营业收入6718.29万元,同比下降30.68%,归属于上市公司股东的净利润664.27万元,同比下降67.94%。目前公司主营业务未发生重大变化,市场环境、行业政策没有发生重大调整,股价短期内连续上涨,涨幅与公司经营情况严重偏离。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-12/doc-ininamih5206238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["APXH","IBB","GSKH","600721","BK0102","BK4585","GDOC","BIOY","BK0216","PBE","LFSC","SBIO","XLVI","WRND","BK4588","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658692990","title":"百花医药(600721.SH):不涉及创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2658692990","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658692990?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 20:03","pubTimestamp":1786449780,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GDOC","WRND","BIOY","SBIO","PBE","APXH","IBB","LFSC","BK4585","XLVI","BBP","GSKH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658667990","title":"百花医药(600721.SH):不涉及创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2658667990","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658667990?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 20:03","pubTimestamp":1786449780,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百花医药(600721.SH)发布股票交易风险提示公告称,公司是以小分子化学仿制药研发为主的CRO企业,主营业务是为客户提供小分子化仿药为主的药物研发注册“一站式”全流程服务,主要研发项目多来自于客户委托加部分的公司自主立项,不涉及创新药研发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK0216","IBB","XLVI","WRND","GSKH","BBP","BK0102","APXH","LFSC","GDOC","BIOY","PBE","SBIO","BK4585","600721"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658962968","title":"东方证券:AI重构创新药研发底座 国内相关产业链公司亦有望受益","url":"https://stock-news.laohu8.com/highlight/detail?id=2658962968","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658962968?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 14:06","pubTimestamp":1786428403,"startTime":"0","endTime":"0","summary":"东方证券主要观点如下:技术颠覆成本,AI重构制药“快与省”是中国创新药崛起的底层逻辑,根基是人才红利和成本优势。专家与AI协同,将真正提升新药研发的成功率并缩短周期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XLVI","BK1564","AGIX","GDOC","BK0188","GSKH","ARTY","LFSC","BK4585","APXH","BIOY","BK0028","IBB","600958","PBE","AIPO","BK4588","SBIO","03958","BK1147","CHAT","BK0276","QTOC","BK0012","WRND","BK0183","BBP","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653584157","title":"创新药研发加速遇“猴荒”","url":"https://stock-news.laohu8.com/highlight/detail?id=2653584157","media":"三里河","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653584157?lang=zh_cn&edition=fundamental","pubTime":"2026-07-22 16:21","pubTimestamp":1784708497,"startTime":"0","endTime":"0","summary":"“要站在‘猴’里,不要像猴子一样站在那里。”资本市场从来不缺故事。近期,昭衍新药业绩暴增,原因是实验猴市场价格上涨,带动公司手里的“猴子资产”大幅增值,多家相关概念公司股价也跟风大涨。甚至有人顺藤摸瓜,挖出了“香蕉概念”。网友戏称:这是产业链挖掘最深的一次。一只猴子,为什么能扰动资本市场?答案藏在药物的研发链条里。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607223817277458.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607223817277458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SBIO","XLVI","BK4585","WRND","LFSC","APXH","IBB","BBP","BIOY","BK4588","GDOC","GSKH","PBE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}